Insight

Nelson Dusetti

May 5, 2025, 14:24

Nelson Dusetti: Advancing Pancreatic Cancer Research with ARARD Foundation

Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre of Marseille (CRCM), shared a post on LinkedIn:

“Tumor plasticity and resistance remain major barriers in pancreatic cancer treatment. Thanks to the support of the ARARD Foundation – Home Care Provider, our team is advancing research to better understand and overcome these challenges. This grant supports and strengthens the work of two early-career researchers: Brice Chanez, clinical oncologist at Paoli-Calmettes Institute, and Nicolas Fraunhoffer Ph.D., translational researcher at CRCM – Cancer Research Centre of Marseille. This project relies on the Pancreas-View transcriptomic signature to molecularly stratify pancreatic tumors and uncover key mechanisms of treatment adaptation, plasticity and resistance – paving the way for more personalized therapies.”

More posts featuring Nelson Dusetti.

ARARD Brice Chanez cancer Cancer Research Centre of Marseille CRCM Nelson Dusetti. Nicolas Fraunhoffer OncoDaily Oncology Pancreatic Cancer Paoli-Calmettes Institute

Cyril Konto: I Trademarked The Word ‘Multispecific’ The Day I Arrived

Levi Garraway: Transforming Oncology Through Precision, Resilience And Heart

20 Posts Not to Miss from ASCO 2025

Jessie J Diagnosed with Early-Stage Breast Cancer: What Is the Prognosis?

Robin Zon: The Official End of My Term as ASCO President